Issue contents
Download PDF of article
Download CIF
3D view
Navigation
Highlighting
Dictionary of Crystallography reference
IUPAC Gold Book reference
more ...
Download citation
FormatBIBTeX
EndNote
RefMan
Refer
Medline
CIF
SGML
Plain Text
share
Previous article
Next article
Previous article
Issue contents
Download PDF of article
Download CIF
3D view
Navigation
Highlighting
Dictionary of Crystallography reference
IUPAC Gold Book reference
more ...
Download citation
FormatBIBTeX
EndNote
RefMan
Refer
Medline
CIF
SGML
Plain Text
share
Next article

organic compounds\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Volume 67| Part 10| October 2011| Page o2570
https://doi.org/10.1107/S1600536811034726

4-[2-(4-Bromo­phen­yl)hydrazinyl­­idene]-3-methyl-5-oxo-4,5-di­hydro-1H-pyrazole-1-carbo­thio­amide

Hoong-Kun Fun,a*‡ Madhukar Hemamalini,a Shobhitha Shettyb and BalaKrishna Kallurayab

aX-ray Crystallography Unit, School of Physics, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia, and bDepartment of Studies in Chemistry, Mangalore University, Mangalagangotri, Mangalore 574 199, India
*Correspondence e-mail: hkfun@usm.my

(Received 19 August 2011; accepted 24 August 2011; online 14 September 2011)

In the title compound, C11H10BrN5OS, the approximately planar pyrazole ring [maximum deviation = 0.014 (2) Å] forms a dihedral angle of 5.49 (13)° with the benzene ring. An intra­molecular N—H⋯O hydrogen bond generates an S(6) ring motif. In the crystal, mol­ecules are linked through inter­molecular N—H⋯S and N—H⋯O hydrogen bonds, forming a two-dimensional network parallel to (100). A short Br⋯Br contact of 3.5114 (6) Å is also observed.

Related literature

For details and applications of pyrazole compounds, see: Isloor et al. (2009[Isloor, A. M., Kalluraya, B. & Shetty, P. (2009). Eur. J. Med. Chem. 44, 3784-3787.]); Rai et al. (2008[Rai, N. S., Kalluraya, B., Lingappa, B., Shenoy, S. & Puranic, V. G. (2008). Eur. J. Med. Chem. 43, 1715-1720.]) Bradbury & Pucci (2008[Bradbury, B. J. & Pucci, M. J. (2008). Curr. Opin. Pharmacol., 8, 574-581.]); Girisha et al. (2010[Girisha, K.S., Kalluraya, B., Narayana, V. & Padmashree (2010). Eur. J. Med. Chem. 45, 4640-4644.]). For standard bond-length data, see: Allen et al. (1987[Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.]). For hydrogen-bond motifs, see: Bernstein et al. (1995[Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.]).

[Scheme 1]

Experimental

Crystal data

  • C11H10BrN5OS

  • Mr = 340.21

  • Monoclinic, C 2/c

  • a = 25.6080 (18) Å

  • b = 11.6686 (8) Å

  • c = 9.0823 (6) Å

  • β = 98.907 (2)°

  • V = 2681.2 (3) Å3

  • Z = 8

  • Mo Kα radiation

  • μ = 3.22 mm−1

  • T = 296 K

  • 0.48 × 0.33 × 0.17 mm
Data collection

  • Bruker APEXII DUO CCD area-detector diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2009[Bruker (2009). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]) Tmin = 0.306, Tmax = 0.609

  • 15576 measured reflections

  • 3869 independent reflections

  • 2776 reflections with I > 2σ(I)

  • Rint = 0.034
Refinement

  • R[F2 > 2σ(F2)] = 0.040

  • wR(F2) = 0.127

  • S = 1.03

  • 3869 reflections

  • 185 parameters

  • H atoms treated by a mixture of independent and constrained refinement

  • Δρmax = 0.46 e Å−3

  • Δρmin = −0.75 e Å−3

Table 1
Hydrogen-bond geometry (Å, °)

D—H⋯A D—H H⋯A D⋯A D—H⋯A
N4—H1N4⋯O1 0.82 (4) 2.27 (4) 2.788 (3) 121 (3)
N5—H1N5⋯S1i 0.80 (4) 2.84 (4) 3.522 (2) 144 (3)
N5—H2N5⋯O1ii 0.82 (3) 2.11 (4) 2.925 (3) 175 (4)
Symmetry codes: (i) [x, -y+1, z+{\script{1\over 2}}]; (ii) [-x+{\script{1\over 2}}, y-{\script{1\over 2}}, -z+{\script{1\over 2}}].

Data collection: APEX2 (Bruker, 2009[Bruker (2009). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT (Bruker, 2009[Bruker (2009). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL and PLATON (Spek, 2009[Spek, A. L. (2009). Acta Cryst. D65, 148-155.]); software used to prepare material for publication: SHELXTL and PLATON.

Supporting information

Crystal structure: contains datablocks global, I. DOI: https://doi.org/10.1107/S1600536811034726/lh5323sup1.cif

Structure factors: contains datablock I. DOI: https://doi.org/10.1107/S1600536811034726/lh5323Isup2.hkl

Supporting information file. DOI: https://doi.org/10.1107/S1600536811034726/lh5323Isup3.cml

checkCIF report


Comment top

The pyrazole ring is a prominent structural moiety found in numerous pharmaceutically active compounds. This is mainly due to the easy preparation and the important pharmacological activity. Therefore, the synthesis and selective functionalization of pyrazoles have been the focus of active research area over the years (Isloor et al., 2009). Pyrazoles have been reported to possess antibacterial activity (Rai et al., 2008), and inhibitor activity against DNA gyrase and topoisomerase IV at their respective ATP-binding sites (Bradbury & Pucci, 2008). Moreover, pyrazole-containing compounds have received considerable attention owing to their diverse chemotherapeutic potentials including versatile anti-inflammatory and antimicrobial activities (Girisha et al., 2010). The synthetic route followed for obtaining the title compound involves the diazotization of substituted anilines to give the diazonium salts followed by coupling with ethyl acetoacetate in the presence of sodium acetate to give the corresponding oxobutanoate which on further reaction with thiosemicarbazide in acetic acid gave the required thioamides.

The asymmetric unit of the title compound (I) is shown in Fig. 1. The pyrazole (N1,N2/C1–C3) ring is approximately planar, with a maximum deviation of 0.014 (2) Å for atom N1. The dihedral angle between the benzene (C4–C9) ring and the pyrazole (N1,N2/C1–C3) ring is 5.49 (13)°. An intramolecular N4—H1N4···O1 hydrogen bond generates an S(6) ring motif (Bernstein et al., 1995). The bond lengths (Allen et al., 1987) and angles are within normal ranges.

In the crystal structure (Fig. 2) molecules are linked through intermolecular N5—H1N5···S1i and N5—H2N5···O1ii hydrogen bonds (Table 1) forming a two-dimensional network parallel to (1 0 0). A short Br···Br contact of 3.5114 (6) Å is also observed.

Related literature top

For details and applications of pyrazole compounds, see: Isloor et al. (2009); Rai et al. (2008) Bradbury & Pucci (2008); Girisha et al. (2010). For standard bond-length data, see: Allen et al. (1987). For hydrogen-bond motifs, see: Bernstein et al. (1995).

Experimental top

To a solution of ethyl-2-[(4-bromophenyl)hydrazono]-3-oxobutanoate (0.01 mol) dissolved in glacial acetic acid (20 ml), a solution of thiosemicarbazide (0.02 mol) in glacial acetic acid (25 ml) was added and the mixture was refluxed for 4 h. This was cooled and allowed to stand overnight. The solid product which separated out was filtered and dried. It was then recrystallized from ethanol. Crystals suitable for X-ray analysis were obtained by slow evaporation of a solution of (I) in a 1:2 mixture of DMF and ethanol.

Refinement top

Atoms H1N4, H1N5 and H2N5 were located in difference Fourier maps and refined freely [N–H = 0.81 (4)–0.82 (3) Å]. The remaining H atoms were positioned geometrically [C–H = 0.93 or 0.96 Å] and were refined using a riding model, with Uiso(H) = 1.2 or 1.5 Ueq(C). A rotating group model was applied to the methyl groups.

Structure description top

The pyrazole ring is a prominent structural moiety found in numerous pharmaceutically active compounds. This is mainly due to the easy preparation and the important pharmacological activity. Therefore, the synthesis and selective functionalization of pyrazoles have been the focus of active research area over the years (Isloor et al., 2009). Pyrazoles have been reported to possess antibacterial activity (Rai et al., 2008), and inhibitor activity against DNA gyrase and topoisomerase IV at their respective ATP-binding sites (Bradbury & Pucci, 2008). Moreover, pyrazole-containing compounds have received considerable attention owing to their diverse chemotherapeutic potentials including versatile anti-inflammatory and antimicrobial activities (Girisha et al., 2010). The synthetic route followed for obtaining the title compound involves the diazotization of substituted anilines to give the diazonium salts followed by coupling with ethyl acetoacetate in the presence of sodium acetate to give the corresponding oxobutanoate which on further reaction with thiosemicarbazide in acetic acid gave the required thioamides.

The asymmetric unit of the title compound (I) is shown in Fig. 1. The pyrazole (N1,N2/C1–C3) ring is approximately planar, with a maximum deviation of 0.014 (2) Å for atom N1. The dihedral angle between the benzene (C4–C9) ring and the pyrazole (N1,N2/C1–C3) ring is 5.49 (13)°. An intramolecular N4—H1N4···O1 hydrogen bond generates an S(6) ring motif (Bernstein et al., 1995). The bond lengths (Allen et al., 1987) and angles are within normal ranges.

In the crystal structure (Fig. 2) molecules are linked through intermolecular N5—H1N5···S1i and N5—H2N5···O1ii hydrogen bonds (Table 1) forming a two-dimensional network parallel to (1 0 0). A short Br···Br contact of 3.5114 (6) Å is also observed.

For details and applications of pyrazole compounds, see: Isloor et al. (2009); Rai et al. (2008) Bradbury & Pucci (2008); Girisha et al. (2010). For standard bond-length data, see: Allen et al. (1987). For hydrogen-bond motifs, see: Bernstein et al. (1995).

Computing details top

Data collection: APEX2 (Bruker, 2009); cell refinement: SAINT (Bruker, 2009); data reduction: SAINT (Bruker, 2009); program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009); software used to prepare material for publication: SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009).

Figures top
[Figure 1] Fig. 1. The molecular structure of title compound, showing 50% probability displacement ellipsoids. An intramolecular hydrogen bond is shown by a dashed line.
[Figure 2] Fig. 2. The crystal packing of (I) with hydrogen bonds shown as dashed lines.
4-[2-(4-Bromophenyl)hydrazinylidene]-3-methyl-5-oxo-4,5-dihydro- 1H-pyrazole-1-carbothioamide top
Crystal data top
C11H10BrN5OSF(000) = 1360
Mr = 340.21Dx = 1.686 Mg m−3
Monoclinic, C2/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -C 2ycCell parameters from 4204 reflections
a = 25.6080 (18) Åθ = 2.9–27.8°
b = 11.6686 (8) ŵ = 3.22 mm−1
c = 9.0823 (6) ÅT = 296 K
β = 98.907 (2)°Slab, orange
V = 2681.2 (3) Å30.48 × 0.33 × 0.17 mm
Z = 8
Data collection top
Bruker APEXII DUO CCD area-detector
diffractometer		3869 independent reflections
Radiation source: fine-focus sealed tube2776 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.034
φ and ω scansθmax = 30.0°, θmin = 2.9°
Absorption correction: multi-scan
(SADABS; Bruker, 2009)		h = −36→36
Tmin = 0.306, Tmax = 0.609k = −16→14
15576 measured reflectionsl = −12→12
Refinement top
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.040Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.127H atoms treated by a mixture of independent and constrained refinement
S = 1.03 w = 1/[σ2(Fo2) + (0.0646P)2 + 2.3027P]
where P = (Fo2 + 2Fc2)/3
3869 reflections(Δ/σ)max = 0.001
185 parametersΔρmax = 0.46 e Å−3
0 restraintsΔρmin = −0.75 e Å−3
Crystal data top
C11H10BrN5OSV = 2681.2 (3) Å3
Mr = 340.21Z = 8
Monoclinic, C2/cMo Kα radiation
a = 25.6080 (18) ŵ = 3.22 mm−1
b = 11.6686 (8) ÅT = 296 K
c = 9.0823 (6) Å0.48 × 0.33 × 0.17 mm
β = 98.907 (2)°
Data collection top
Bruker APEXII DUO CCD area-detector
diffractometer		3869 independent reflections
Absorption correction: multi-scan
(SADABS; Bruker, 2009)		2776 reflections with I > 2σ(I)
Tmin = 0.306, Tmax = 0.609Rint = 0.034
15576 measured reflections
Refinement top
R[F2 > 2σ(F2)] = 0.0400 restraints
wR(F2) = 0.127H atoms treated by a mixture of independent and constrained refinement
S = 1.03Δρmax = 0.46 e Å−3
3869 reflectionsΔρmin = −0.75 e Å−3
185 parameters
Special details top

Geometry. All s.u.'s (except the s.u. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell s.u.'s are taken into account individually in the estimation of s.u.'s in distances, angles and torsion angles; correlations between s.u.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell s.u.'s is used for estimating s.u.'s involving l.s. planes.

Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) top
xyzUiso*/Ueq
S10.24780 (3)0.67093 (6)0.16175 (6)0.04971 (18)
Br10.476115 (14)1.36166 (3)0.95277 (4)0.07714 (17)
O10.29888 (8)0.85438 (14)0.39141 (19)0.0476 (4)
N10.30362 (8)0.65467 (16)0.43648 (19)0.0377 (4)
N20.32861 (9)0.58425 (17)0.5541 (2)0.0442 (5)
N30.37576 (9)0.85410 (17)0.6771 (2)0.0433 (4)
N40.36660 (9)0.95754 (18)0.6236 (2)0.0432 (4)
N50.26122 (10)0.4932 (2)0.3443 (2)0.0483 (5)
C10.35129 (9)0.7684 (2)0.6042 (2)0.0399 (5)
C20.31496 (9)0.77032 (19)0.4632 (2)0.0358 (4)
C30.35624 (11)0.6506 (2)0.6496 (3)0.0464 (6)
C40.39352 (9)1.0510 (2)0.6975 (2)0.0398 (5)
C50.43053 (11)1.0338 (2)0.8242 (3)0.0536 (6)
H5A0.43880.96000.85880.064*
C60.45488 (11)1.1273 (3)0.8982 (3)0.0581 (7)
H6A0.47941.11690.98400.070*
C70.44277 (10)1.2359 (2)0.8449 (3)0.0500 (6)
C80.40611 (11)1.2539 (2)0.7174 (3)0.0517 (6)
H8A0.39831.32760.68180.062*
C90.38156 (11)1.1601 (2)0.6447 (3)0.0498 (6)
H9A0.35681.17050.55950.060*
C100.27077 (9)0.6012 (2)0.3187 (2)0.0373 (5)
C110.38809 (16)0.6072 (3)0.7892 (4)0.0753 (10)
H11A0.38280.52610.79690.113*
H11B0.37720.64500.87330.113*
H11C0.42480.62240.78750.113*
H1N40.3475 (14)0.980 (3)0.548 (4)0.064 (9)*
H1N50.2727 (15)0.468 (3)0.425 (4)0.077 (11)*
H2N50.2458 (13)0.456 (3)0.275 (4)0.057 (9)*
Atomic displacement parameters (Å2) top
U11U22U33U12U13U23
S10.0660 (4)0.0450 (4)0.0326 (3)0.0018 (3)−0.0098 (2)0.0007 (2)
Br10.0707 (2)0.0514 (2)0.0982 (3)−0.00776 (14)−0.02193 (18)−0.02813 (16)
O10.0595 (11)0.0342 (9)0.0437 (9)0.0036 (7)−0.0085 (8)0.0020 (6)
N10.0453 (10)0.0322 (10)0.0316 (8)−0.0025 (7)−0.0064 (7)0.0006 (6)
N20.0550 (12)0.0331 (10)0.0387 (9)−0.0027 (9)−0.0111 (8)0.0047 (7)
N30.0467 (11)0.0381 (11)0.0420 (10)−0.0061 (8)−0.0032 (8)−0.0022 (7)
N40.0470 (11)0.0362 (11)0.0422 (10)−0.0034 (8)−0.0064 (8)−0.0040 (8)
N50.0642 (14)0.0411 (12)0.0341 (9)−0.0113 (10)−0.0092 (9)−0.0014 (8)
C10.0442 (12)0.0366 (12)0.0350 (9)−0.0020 (9)−0.0055 (8)−0.0002 (8)
C20.0408 (11)0.0326 (11)0.0327 (9)0.0001 (9)0.0018 (8)−0.0002 (8)
C30.0529 (14)0.0399 (13)0.0406 (11)−0.0057 (10)−0.0112 (10)0.0037 (9)
C40.0388 (11)0.0379 (12)0.0411 (10)−0.0039 (9)0.0012 (9)−0.0064 (9)
C50.0528 (15)0.0406 (14)0.0599 (14)0.0007 (11)−0.0151 (11)−0.0046 (11)
C60.0519 (15)0.0527 (17)0.0606 (15)0.0019 (12)−0.0203 (12)−0.0123 (12)
C70.0441 (13)0.0413 (14)0.0609 (14)−0.0045 (10)−0.0036 (10)−0.0158 (11)
C80.0554 (15)0.0351 (13)0.0600 (14)−0.0030 (11)−0.0053 (11)−0.0044 (10)
C90.0531 (15)0.0413 (14)0.0492 (12)−0.0033 (11)−0.0104 (10)−0.0018 (10)
C100.0412 (11)0.0388 (12)0.0301 (9)−0.0009 (9)−0.0006 (8)−0.0038 (8)
C110.095 (2)0.0536 (17)0.0604 (17)−0.0116 (17)−0.0407 (16)0.0130 (13)
Geometric parameters (Å, º) top
S1—C101.667 (2)C1—C21.462 (3)
Br1—C71.893 (2)C3—C111.486 (3)
O1—C21.214 (3)C4—C91.377 (4)
N1—C21.394 (3)C4—C51.387 (3)
N1—C101.401 (3)C5—C61.378 (4)
N1—N21.420 (3)C5—H5A0.9300
N2—C31.289 (3)C6—C71.375 (4)
N3—C11.304 (3)C6—H6A0.9300
N3—N41.308 (3)C7—C81.389 (4)
N4—C41.404 (3)C8—C91.379 (4)
N4—H1N40.82 (3)C8—H8A0.9300
N5—C101.311 (3)C9—H9A0.9300
N5—H1N50.81 (4)C11—H11A0.9600
N5—H2N50.81 (4)C11—H11B0.9600
C1—C31.435 (3)C11—H11C0.9600
C2—N1—C10130.42 (19)C6—C5—H5A120.3
C2—N1—N2111.85 (17)C4—C5—H5A120.3
C10—N1—N2117.67 (18)C7—C6—C5119.8 (2)
C3—N2—N1107.16 (19)C7—C6—H6A120.1
C1—N3—N4118.3 (2)C5—C6—H6A120.1
N3—N4—C4119.5 (2)C6—C7—C8121.3 (2)
N3—N4—H1N4131 (2)C6—C7—Br1118.24 (19)
C4—N4—H1N4110 (2)C8—C7—Br1120.5 (2)
C10—N5—H1N5117 (3)C9—C8—C7118.6 (3)
C10—N5—H2N5117 (2)C9—C8—H8A120.7
H1N5—N5—H2N5125 (4)C7—C8—H8A120.7
N3—C1—C3125.1 (2)C4—C9—C8120.4 (2)
N3—C1—C2128.6 (2)C4—C9—H9A119.8
C3—C1—C2106.37 (19)C8—C9—H9A119.8
O1—C2—N1130.2 (2)N5—C10—N1113.5 (2)
O1—C2—C1126.8 (2)N5—C10—S1124.77 (17)
N1—C2—C1103.00 (18)N1—C10—S1121.74 (17)
N2—C3—C1111.6 (2)C3—C11—H11A109.5
N2—C3—C11122.7 (2)C3—C11—H11B109.5
C1—C3—C11125.7 (2)H11A—C11—H11B109.5
C9—C4—C5120.5 (2)C3—C11—H11C109.5
C9—C4—N4119.0 (2)H11A—C11—H11C109.5
C5—C4—N4120.4 (2)H11B—C11—H11C109.5
C6—C5—C4119.3 (3)
C2—N1—N2—C3−2.1 (3)C2—C1—C3—C11−178.2 (3)
C10—N1—N2—C3−179.5 (2)N3—N4—C4—C9−176.6 (2)
C1—N3—N4—C4−178.2 (2)N3—N4—C4—C51.5 (4)
N4—N3—C1—C3−178.7 (2)C9—C4—C5—C60.8 (4)
N4—N3—C1—C22.4 (4)N4—C4—C5—C6−177.4 (3)
C10—N1—C2—O10.6 (4)C4—C5—C6—C7−0.8 (5)
N2—N1—C2—O1−176.3 (2)C5—C6—C7—C80.3 (5)
C10—N1—C2—C1179.5 (2)C5—C6—C7—Br1178.7 (2)
N2—N1—C2—C12.6 (2)C6—C7—C8—C90.3 (4)
N3—C1—C2—O1−4.0 (4)Br1—C7—C8—C9−178.1 (2)
C3—C1—C2—O1176.9 (2)C5—C4—C9—C8−0.2 (4)
N3—C1—C2—N1177.0 (3)N4—C4—C9—C8178.0 (2)
C3—C1—C2—N1−2.0 (3)C7—C8—C9—C4−0.4 (4)
N1—N2—C3—C10.7 (3)C2—N1—C10—N5−167.1 (2)
N1—N2—C3—C11179.8 (3)N2—N1—C10—N59.7 (3)
N3—C1—C3—N2−178.2 (3)C2—N1—C10—S113.9 (4)
C2—C1—C3—N20.9 (3)N2—N1—C10—S1−169.28 (17)
N3—C1—C3—C112.6 (5)
Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
N4—H1N4···O10.82 (4)2.27 (4)2.788 (3)121 (3)
N5—H1N5···S1i0.80 (4)2.84 (4)3.522 (2)144 (3)
N5—H2N5···O1ii0.82 (3)2.11 (4)2.925 (3)175 (4)
Symmetry codes: (i) x, −y+1, z+1/2; (ii) −x+1/2, y−1/2, −z+1/2.

Experimental details

Crystal data
Chemical formulaC11H10BrN5OS
Mr340.21
Crystal system, space groupMonoclinic, C2/c
Temperature (K)296
a, b, c (Å)25.6080 (18), 11.6686 (8), 9.0823 (6)
β (°) 98.907 (2)
V (Å3)2681.2 (3)
Z8
Radiation typeMo Kα
µ (mm−1)3.22
Crystal size (mm)0.48 × 0.33 × 0.17
Data collection
DiffractometerBruker APEXII DUO CCD area-detector
Absorption correctionMulti-scan
(SADABS; Bruker, 2009)
Tmin, Tmax0.306, 0.609
No. of measured, independent and
observed [I > 2σ(I)] reflections		15576, 3869, 2776
Rint0.034
(sin θ/λ)max (Å−1)0.703
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.040, 0.127, 1.03
No. of reflections3869
No. of parameters185
H-atom treatmentH atoms treated by a mixture of independent and constrained refinement
Δρmax, Δρmin (e Å−3)0.46, −0.75

Computer programs: APEX2 (Bruker, 2009), SAINT (Bruker, 2009), SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009).

Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
N4—H1N4···O10.82 (4)2.27 (4)2.788 (3)121 (3)
N5—H1N5···S1i0.80 (4)2.84 (4)3.522 (2)144 (3)
N5—H2N5···O1ii0.82 (3)2.11 (4)2.925 (3)175 (4)
Symmetry codes: (i) x, −y+1, z+1/2; (ii) −x+1/2, y−1/2, −z+1/2.
 

Footnotes

‡Thomson Reuters ResearcherID: A-3561-2009.

Acknowledgements

HKF and MH thank the Malaysian Government and Universiti Sains Malaysia for the Research University Grant No. 1001/PFIZIK/811160. MH also thanks Universiti Sains Malaysia for a post-doctoral research fellowship.

References

First citationAllen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1–19.  CSD CrossRef Web of Science Google Scholar
 First citationBernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555–1573.  CrossRef CAS Web of Science Google Scholar
 First citationBradbury, B. J. & Pucci, M. J. (2008). Curr. Opin. Pharmacol., 8, 574–581.  CrossRef PubMed CAS Google Scholar
 First citationBruker (2009). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.  Google Scholar
 First citationGirisha, K.S., Kalluraya, B., Narayana, V. & Padmashree (2010). Eur. J. Med. Chem. 45, 4640–4644.  Google Scholar
 First citationIsloor, A. M., Kalluraya, B. & Shetty, P. (2009). Eur. J. Med. Chem. 44, 3784–3787.  Web of Science CrossRef PubMed CAS Google Scholar
 First citationRai, N. S., Kalluraya, B., Lingappa, B., Shenoy, S. & Puranic, V. G. (2008). Eur. J. Med. Chem. 43, 1715–1720.  Web of Science PubMed Google Scholar
 First citationSheldrick, G. M. (2008). Acta Cryst. A64, 112–122.  Web of Science CrossRef CAS IUCr Journals Google Scholar
 First citationSpek, A. L. (2009). Acta Cryst. D65, 148–155.  Web of Science CrossRef CAS IUCr Journals Google Scholar

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Volume 67| Part 10| October 2011| Page o2570
https://doi.org/10.1107/S1600536811034726
Follow Acta Cryst. E
Sign up for e-alerts
E-alerts
Follow Acta Cryst. on Twitter
Twitter
Follow us on facebook
Facebook
Sign up for RSS feeds
RSS